Skip to main content
OpenTrials
Completed

NCT Number: NCT05640076

Effects of a 24/7 Palliative Care Service Integration in a Metropolitan Area on Non-oncologic Patients

This retrospective observational pre-post study aims to test the effects of introducing a remote telephonic consultation availability from the Palliative Care Service for a cohort of non-oncologic patients followed by the same service, their relatives, and the Emergency Medical Services (EMS) and family care physicians taking care of them.

The main question[s] it aims to answer are:

* Does the introduction of a remote telephonic consultation availability affect the rate of ED access of non-oncologic Palliative-care followed patients during their last 90 days of life? * Does the introduction of a remote telephonic consultation availability have an effect on the rate of EMS requests for these patients during their last 90 days of life? * Which are the main topics of the calls to the Palliative Care Service?

Due to the emergence of COVID-19 pandemic during the study period, a parallel cohort of oncologic patients under 24/7 palliative care by the same service during both the observation periods will be used as reference.

Participants will be followed up from the date of taking-over request to the Palliative Care Service to their death or the end of the period of observation if followup began during their last 90 days of life.

Otherwise, for those being already under home palliative care at the 90th day before their death, follow up will begin at that day.

Researchers will compare two time periods to see if the introduction of a remote telephonic consultation availability has an effect on the supra-mentioned aims.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Azienda Unità Sanitaria Locale, Bologna, Italy

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients followed by the Metropolitan Palliative Care Service of Bologna
  • Residency in Bologna Metropolitan city

Exclusion criteria

  • Incomplete data
  • Residency outside Bologna Metropolitan City

Treatment and study plan

24/7 Telephonic Palliative Care Service availability

Other

Metropolitan Palliative Care Service-implemented 24/7 telephonic availability service for the patients, their relatives, the EMS and Primary Care physicians taking care of them.

After consultation, if the information and medical suggestions are not sufficient, an urgent ambulatory or home visit could be planned.

Primary outcomes

  1. Emergency Department Admission rate of patients followed by the Palliative Care Service

    Time frame: 48 months

Secondary outcomes

  1. EMS calls rate from patients followed by the Palliative Care Service

    Time frame: 48 months

  2. Main topics of the calls received from the Palliative Care Service after the full implementation of a 24/7 service

    Time frame: 24 months

    Classification of the topics of the calls into 5 main classes: "Clinical questions", "Caregiver Support", "Definition of care pathway", "Palliative sedation", "Other communications".

    The relative frequency of each main topic will be reported

Sponsors and collaborators

Lead sponsor

Azienda Usl di Bologna

Other Gov

Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Dec 7, 2022
Registry last updated
Jul 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.